Nitrates and newer antianginals Flashcards

1
Q

Nitrates provide an exogenous source of vasodilator nitric oxide (NO•, usually given as NO), a very short-lived free radical, thereby inducing coronary vasodilation even when endogenous production of NO• is impaired by CAD. Thus nitrates act differently from the other classes of antianginals (see Fig. 2-2).

A

Nitrates provide an exogenous source of vasodilator nitric oxide (NO•, usually given as NO), a very short-lived free radical, thereby inducing coronary vasodilation even when endogenous production of NO• is impaired by CAD. Thus nitrates act differently from the other classes of antianginals (see Fig. 2-2).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Chronic use of nitrates produces ……, a significant clinical problem. The main focus of current clinical work remains on strategies to minimize or prevent the development of …….., with the major emphasis on the adverse role of excess NO• that produces harmful peroxynitrite. The thrust of basic work has shifted to endogenously produced NO• as a ubiquitous physiologic messenger. Although endogenously produced NO• has many functions (such as a role in vagal neurotransmission) quite different from the NO• derived from exogenous nitrates, there are important shared vasodilatory effects.

A

Chronic use of nitrates produces tolerance, a significant clinical problem. The main focus of current clinical work remains on strategies to minimize or prevent the development of tolerance, with the major emphasis on the adverse role of excess NO• that produces harmful peroxynitrite. The thrust of basic work has shifted to endogenously produced NO• as a ubiquitous physiologic messenger. Although endogenously produced NO• has many functions (such as a role in vagal neurotransmission) quite different from the NO• derived from exogenous nitrates, there are important shared vasodilatory effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Coronary and peripheral faso…… effects.

A distinction must be made between antianginal and coronary faso……..properties. Nitrates preferentially ……..large coronary arteries and arterioles greater than 100 mcm in diameter 6 to (1) redistribute blood flow along collateral channels and from epicardial to endocardial regions and (2) relieve coronary spasm and dynamic stenosis, especially at epicardial sites, including the coronary arterial constriction induced by exercise. Thereby exercise-induced myocardial ischemia is relieved. Thus nitrates are “effective” vasodilators for angina; dipyridamole and other vasodilators acting more distally in the arterial tree are not, but rather have the risk of diverting blood from the ischemic area—a “coronary steal” effect.

A

Coronary and peripheral vasodilatory effects.
A distinction must be made between antianginal and coronary vasodilator properties. Nitrates preferentially dilate large coronary arteries and arterioles greater than 100 mcm in diameter 6 to (1) redistribute blood flow along collateral channels and from epicardial to endocardial regions and (2) relieve coronary spasm and dynamic stenosis, especially at epicardial sites, including the coronary arterial constriction induced by exercise. Thereby exercise-induced myocardial ischemia is relieved. Thus nitrates are “effective” vasodilators for angina; dipyridamole and other vasodilators acting more distally in the arterial tree are not, but rather have the risk of diverting blood from the ischemic area—a “coronary steal” effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The additional peripheral hemodynamic effects of nitrates, originally observed by Lauder Brunton, cannot be ignored. Nitrates do reduce the ……., in addition to the ……… of the heart (Fig. 2-3). The arterial wave reflection from the periphery back to the aorta is altered in such a way that there is “true” …….. reduction, with the aortic systolic pressure falling even though the brachial artery pressure does not change.

A

The additional peripheral hemodynamic effects of nitrates, originally observed by Lauder Brunton, cannot be ignored. Nitrates do reduce the afterload, in addition to the preload of the heart (Fig. 2-3). The arterial wave reflection from the periphery back to the aorta is altered in such a way that there is “true” afterload reduction, with the aortic systolic pressure falling even though the brachial artery pressure does not change.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Reduced oxygen demand.

Nitrates increase the venous capacitance, causing …………… of blood in the peripheral veins and thereby a reduction in ……….. and in ventricular …………. There is less mechanical stress on the myocardial wall and the ………….. demand is reduced. Furthermore, a fall in the aortic …………… also reduces the oxygen demand.

A

Reduced oxygen demand.
Nitrates increase the venous capacitance, causing pooling of blood in the peripheral veins and thereby a reduction in venous return and in ventricular volume. There is less mechanical stress on the myocardial wall and the myocardial oxygen demand is reduced. Furthermore, a fall in the aortic systolic pressure also reduces the oxygen demand.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Endothelium and vascular mechanisms.

The fundamental mechanism of nitrate biological effect is the enzyme-mediated release of highly ……………… from the nitrate molecule (Fig. 2-4).

A

The fundamental mechanism of nitrate biological effect is the enzyme-mediated release of highly unstable NO• from the nitrate molecule (Fig. 2-4).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

An intact vascular endothelium is required for the vasodilatory effects of some vascular active agents (thus acetylcholine physiologically vasodilates but constricts when the endothelium is damaged). Nitrates vasodilator ……………………. Prolonged nitrate therapy with formation of …………………… may, however, inhibit endothelial nitric oxide ……………………. (NOS), which is one of several postulated mechanisms of nitrate tolerance. Similarly, long-term use of long-acting nitrates may cause endothelial dysfunction mediated by ……………….. (see later, Fig. 2-5). Whether this problem extends to aggravation of preexisting endothelial dysfunction is uncertain. Thus nitrate tolerance and endothelial dysfunction have partially shared pathogenetic mechanisms.

A

An intact vascular endothelium is required for the vasodilatory effects of some vascular active agents (thus acetylcholine physiologically vasodilates but constricts when the endothelium is damaged). Nitrates vasodilate whether or not the endothelium is physically intact or functional. Prolonged nitrate therapy with formation of peroxynitrite may, however, inhibit endothelial nitric oxide synthase (NOS), which is one of several postulated mechanisms of nitrate tolerance. Similarly, long-term use of long-acting nitrates may cause endothelial dysfunction mediated by free radicals (see later, Fig. 2-5). Whether this problem extends to aggravation of preexisting endothelial dysfunction is uncertain. Thus nitrate tolerance and endothelial dysfunction have partially shared pathogenetic mechanisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Nitrates, after entering the vessel wall, are bioconverted to release NO•, which stimulates guanylate cyclase to produce ……….; see Fig. 2-4). In addition, NO• acts potentially via direct S-nitrosylation of a number of proteins, altering their physiologic properties via a posttranslational modification step. NO• may also be “scavenged” by the superoxide (O2–) radical, generating peroxynitrate (ONOO–), which in high concentrations contributes to nitrate toxicity (Fig. 2-5) and the induction of nitrate tolerance. Conversely, low concentrations enhance the vasodilator effects of NO•.

A

Nitrates, after entering the vessel wall, are bioconverted to release NO•, which stimulates guanylate cyclase to produce cyclic guanosine monophosphate (GMP; see Fig. 2-4). In addition, NO• acts potentially via direct S-nitrosylation of a number of proteins, altering their physiologic properties via a posttranslational modification step. NO• may also be “scavenged” by the superoxide (O2–) radical, generating peroxynitrate (ONOO–), which in high concentrations contributes to nitrate toxicity (Fig. 2-5) and the induction of nitrate tolerance. Conversely, low concentrations enhance the vasodilator effects of NO•.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Overall the best known mechanism linked to clinical practice is that ………….. in the vascular myocyte falls, and ……………. results (see Fig. 2-4). Sulfhydryl (SH) groups are required for such formation of NO• and the stimulation of guanylate cyclase. Nitroglycerin powerfully dilates when injected into an artery, an effect that is probably limited in humans by reflex adrenergic-mediated vasoconstriction.

Hence (1) nitrates are better …… than …….. dilators, and (2) there is an associated adrenergic reflex ………….. at can be attenuated by concurrent β-blockade.

A

Overall the best known mechanism linked to clinical practice is that calcium in the vascular myocyte falls, and vasodilation results (see Fig. 2-4). Sulfhydryl (SH) groups are required for such formation of NO• and the stimulation of guanylate cyclase. Nitroglycerin powerfully dilates when injected into an artery, an effect that is probably limited in humans by reflex adrenergic-mediated vasoconstriction. Hence (1) nitrates are better ………… than …………… dilators, and (2) there is an associated adrenergic reflex …………… that can be attenuated by concurrent β-blockade.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Effects of NO• on myocardial relaxation and contractile proteins.

NO• has a fundamental role as a modulator of myocardial …………….., mediated at least in part by cyclic GMP (see Fig. 2-4). This effect is independent of the restoration of coronary blood flow that in turn can reverse ischemic diastolic dysfunction. Furthermore, NO• improves ………….function in human heart muscle where it acts on the contractile proteins by increasing ……………… of the springlike cytoskeletal protein titin. In long-term therapy, NO• donors may limit or reverse left ventricular hypertrophy (LVH). These studies raise the possibility that organic nitrates may exert a role in the management of systemic hypertension, in which LVH is a marker and modulator of long-term cardiovascular risk. However, to date, there have been only sporadic clinical investigations.

A

Effects of NO• on myocardial relaxation and contractile proteins.

NO• has a fundamental role as a modulator of myocardial relaxation, mediated at least in part by cyclic GMP (see Fig. 2-4). This effect is independent of the restoration of coronary blood flow that in turn can reverse ischemic diastolic dysfunction. Furthermore, NO• improves diastolic function in human heart muscle where it acts on the contractile proteins by increasing troponin I phosphorylation of the springlike cytoskeletal protein titian. In long-term therapy, NO• donors may limit or reverse left ventricular hypertrophy (LVH). These studies raise the possibility that organic nitrates may exert a role in the management of systemic hypertension, in which LVH is a marker and modulator of long-term cardiovascular risk. However, to date, there have been only sporadic clinical investigations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Antiaggregatory effects.

Organic nitrates mimic the effects of endogenous NO• in inhibiting and potentially reversing…………….. These effects are mediated primarily via the classical pathway of stimulation of activation of soluble guanylate cyclase (see Fig. 2-4).

A

Antiaggregatory effects.
Organic nitrates mimic the effects of endogenous NO• in inhibiting and potentially reversing platelet aggregation. These effects are mediated primarily via the classical pathway of stimulation of activation of soluble guanylate cyclase (see Fig. 2-4).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pharmacokinetics of nitrates
Bioavailability and half-lives.
The various preparations differ so much that each needs to be considered separately. As a group, nitrates are absorbed from the ……….(3)

A

The various preparations differ so much that each needs to be considered separately. As a group, nitrates are absorbed from the mucous membranes, the skin, and the gastrointestinal (GI) tract.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The prototype agent, nitroglycerin, has pharmacokinetics that are not well understood. It rapidly disappears from the blood with a half-life of ……………, largely by extrahepatic mechanisms that convert the parent molecule to longer acting and active dinitrates.

A

The prototype agent, nitroglycerin, has pharmacokinetics that are not well understood. It rapidly disappears from the blood with a half-life of only a few minutes, largely by extrahepatic mechanisms that convert the parent molecule to longer acting and active dinitrates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Isosorbide dinitrate, on the other hand, must first be converted in the liver to active mononitrates (see Fig. 2-4) that have half-lives of approximately ……………….. with ultimate renal excretion.
The mononitrates are completely bioavailable without any hepatic metabolism, with half-lives of ………… In reality, knowledge of pharmacokinetics is of limited interest because of the highly variable relationship between the plasma concentrations of the nitrates, the levels of their active metabolites, and the onset and duration of pharmacologic action that matter most to the clinician.

A

Isosorbide dinitrate, on the other hand, must first be converted in the liver to active mononitrates (see Fig. 2-4) that have half-lives of approximately 4 to 6 hours with ultimate renal excretion.
The mononitrates are completely bioavailable without any hepatic metabolism, with half-lives of 4-6 hours. In reality, knowledge of pharmacokinetics is of limited interest because of the highly variable relationship between the plasma concentrations of the nitrates, the levels of their active metabolites, and the onset and duration of pharmacologic action that matter most to the clinician.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Of the many nitrate preparations (Table 2-1), sublingual nitroglycerin remains the gold standard for acute anginal attacks. In practice, patients are often also given long-acting nitrates. “No matter which long-acting preparation is used, physicians should prescribe the drug in a manner to decrease the likelihood of ……………… This involves an on-off strategy of at least a 10-hour nitrate free interval each day.”

A

Of the many nitrate preparations (Table 2-1), sublingual nitroglycerin remains the gold standard for acute anginal attacks. In practice, patients are often also given long-acting nitrates. “No matter which long-acting preparation is used, physicians should prescribe the drug in a manner to decrease the likelihood of nitrate tolerance. This involves an on-off strategy of at least a 10-hour nitrate free interval each day.”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Nitrate interactions with other drugs

Many of the proposed interactions of nitrates are pharmacodynamic, involving potentiation of vasodilatory effects, as with the …………. However, the chief example of vasodilator interactions is with the selective phosphodiesterase-……………..inhibitors such as sildenafil as used for erectile dysfunction. PDE-5 inhibitors are increasingly used for the therapy of pulmonary hypertension (see Chapter 5) and their benefits in heart failure are being explored. As a group, these agents can cause serious …………. when combined with nitrates (see Fig. 2-5). Hence the package insert of each agent forbids co-administration to patients taking nitrates in any form either regularly or intermittently.

A

Many of the proposed interactions of nitrates are pharmacodynamic, involving potentiation of vasodilatory effects, as with the CCBs. However, the chief example of vasodilator interactions is with the selective phosphodiesterase-5 (PDE-5) inhibitors such as sildenafil as used for erectile dysfunction. PDE-5 inhibitors are increasingly used for the therapy of pulmonary hypertension (see Chapter 5) and their benefits in heart failure are being explored. As a group, these agents can cause serious hypotensive reactions when combined with nitrates (see Fig. 2-5). Hence the package insert of each agent forbids co-administration to patients taking nitrates in any form either regularly or intermittently.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

For example, sildenafil decreases the blood pressure (BP) by approximately 8.4/5.5 mm Hg, and by much more in those taking nitrates. The exertion of sexual intercourse also stresses the cardiovascular system further. As a group, these drugs should also not be given with α-adrenergic blockers. In case of inadvertent PDE-5-nitrate combinations, administration of an α-adrenergic agonist or even of norepinephrine may be needed.

In clinical practice nitrates may be started 24 hours after sildenafil.

A

For example, sildenafil decreases the blood pressure (BP) by approximately 8.4/5.5 mm Hg, and by much more in those taking nitrates. The exertion of sexual intercourse also stresses the cardiovascular system further. As a group, these drugs should also not be given with α-adrenergic blockers. In case of inadvertent PDE-5-nitrate combinations, administration of an α-adrenergic agonist or even of norepinephrine may be needed.

In clinical practice nitrates may be started 24 hours after sildenafil.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Beneficial combination with …………..
There is a beneficial interaction between nitrates and …………. whereby the latter helps to lessen nitrate tolerance, probably acting through inhibition of free radical formation. This may explain why the combination of nitrates and hydralazine is effective in heart failure.

A

Beneficial combination with hydralazine.
There is a beneficial interaction between nitrates and hydralazine whereby the latter helps to lessen nitrate tolerance, probably acting through inhibition of free radical formation. This may explain why the combination of nitrates and hydralazine is effective in heart failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Limitations: Side effects and nitrate failure:

Side effects

………………. is the most serious and headache the most common side effect (Table 2-3). Headache characteristically occurs with sublingual nitroglycerin, and at the start of therapy with long-acting nitrates. Often the headaches pass over while antianginal efficacy is maintained; yet headaches may lead to loss of compliance. Concomitant aspirin may protect from the headaches and from coronary events. In chronic lung disease, arterial ………………… may result from vasodilation and increased venous admixture. Occasionally, prolonged high-dose therapy can cause ………………… (see Table 2-3), which reduces the oxygen-carrying capacity of the blood and the rate of delivery of oxygen to the tissues. Treatment is by intravenous methylene blue (1-2 mg/kg over 5 min).

A

Hypotension is the most serious and headache the most common side effect (Table 2-3). Headache characteristically occurs with sublingual nitroglycerin, and at the start of therapy with long-acting nitrates. Often the headaches pass over while antianginal efficacy is maintained; yet headaches may lead to loss of compliance. Concomitant aspirin may protect from the headaches and from coronary events. In chronic lung disease, arterial hypoxemia may result from vasodilation and increased venous admixture. Occasionally, prolonged high-dose therapy can cause methemoglobinemia (see Table 2-3), which reduces the oxygen-carrying capacity of the blood and the rate of delivery of oxygen to the tissues. Treatment is by intravenous methylene blue (1-2 mg/kg over 5 min).

20
Q

Failure of nitrate therapy

Apart from issues of noncompliance, the principal reason for limitation of therapeutic response to nitrates can be categorized as NO• resistance, “true” nitrate tolerance and nitrate “pseudo”-tolerance, alone, or in combination (Table 2-4

A

Apart from issues of noncompliance, the principal reason for limitation of therapeutic response to nitrates can be categorized as NO• resistance, “true” nitrate tolerance and nitrate “pseudo”-tolerance, alone, or in combination (Table 2-4

21
Q

Acute heart failure and acute pulmonary edema
No clear guidelines exist regarding management of acute decompensated heart failure. Randomized controlled trials are needed to develop practice guidelines.
In acute pulmonary edema from various causes, including AMI, nitroglycerin can be strikingly effective, with some risk of precipitous falls in BP and of tachycardia or bradycardia. Intravenous nitroglycerin, however, is usually a better method to administer nitroglycerin because the dose can be rapidly adjusted upward or downward depending on the clinical and hemodynamic response.

A

Acute heart failure and acute pulmonary edema
No clear guidelines exist regarding management of acute decompensated heart failure.
In acute pulmonary edema from various causes, including AMI, nitroglycerin can be strikingly effective, with some risk of precipitous falls in BP and of tachycardia or bradycardia. Intravenous nitroglycerin, however, is usually a better method to administer nitroglycerin because the dose can be rapidly adjusted upward or downward depending on the clinical and hemodynamic response.

22
Q

Congestive heart failure
Both short- and long-acting nitrates are used as unloading agents in the relief of symptoms in acute and chronic heart failure. Their dilating effects are more pronounced on ……… than on arterioles, so they are best suited to patients with raised pulmonary …………… and clinical features of pulmonary ……………

A

Congestive heart failure
Both short- and long-acting nitrates are used as unloading agents in the relief of symptoms in acute and chronic heart failure. Their dilating effects are more pronounced on veins than on arterioles, so they are best suited to patients with raised pulmonary wedge pressure and clinical features of pulmonary congestion.

23
Q

The combination of high-dose isosorbide dinitrate (60 mg four times daily) plus hydralazine was better than placebo in decreasing mortality, yet nonetheless inferior to an ACE inhibitor in severe congestive heart failure (CHF). Dinitrate-hydralazine may therefore be chosen when a patient cannot tolerate an ACE inhibitor or it may be added to the therapy of heart failure, the latter indication being well validated in black patients.

A

The combination of high-dose isosorbide dinitrate (60 mg four times daily) plus hydralazine was better than placebo in decreasing mortality, yet nonetheless inferior to an ACE inhibitor in severe congestive heart failure (CHF). Dinitrate-hydralazine may therefore be chosen when a patient cannot tolerate an ACE inhibitor or it may be added to the therapy of heart failure, the latter indication being well validated in black patients.

24
Q

Nitrate tolerance remains a problem. Intermittent dosing designed to counter periods of expected dyspnea (at night, anticipated exercise) is one sensible policy.40 Escalating doses of nitrates provide only a short-term solution and should be avoided in general. A third possible option is co-therapy with ……………or…………… or both, which might blunt nitrate tolerance. Nitrate patches have given variable results in CHF.

A

Nitrate tolerance remains a problem. Intermittent dosing designed to counter periods of expected dyspnea (at night, anticipated exercise) is one sensible policy.40 Escalating doses of nitrates provide only a short-term solution and should be avoided in general. A third possible option is co-therapy with ACE inhibitors or hydralazine or both, which might blunt nitrate tolerance. Nitrate patches have given variable results in CHF.

25
Q

Nitrate tolerance and nitric oxide resistance
Nitrate tolerance

Nitrate tolerance often limits nitrate efficacy. Thus longer-acting nitrates, although providing higher and better-sustained blood nitrate levels, paradoxically often seem to lose their efficacy with time. This is the phenomenon of nitrate tolerance (see Fig. 2-4).

A

Nitrate tolerance and nitric oxide resistance
Nitrate tolerance

Nitrate tolerance often limits nitrate efficacy. Thus longer-acting nitrates, although providing higher and better-sustained blood nitrate levels, paradoxically often seem to lose their efficacy with time. This is the phenomenon of nitrate tolerance (see Fig. 2-4).

26
Q

A number of hypotheses have been proposed to account for development of nitrate tolerance. These may be summarized as follows:..?

A
  1. Impaired nitrate bioactivation: Several investigators have demonstrated that the induction of tolerance to nitroglycerin and to other organic nitrates is relatively nitrate-specific, with minimal cross-tolerance to more direct activators of soluble guanylate cyclase, including NO• itself
2.
Aldehyde dehydrogenase (ALDH). ALDH is an example of such an enzyme (see Fig. 2-4). Aldehydes are highly toxic compounds that generate reactive oxidative stress in the form of reactive oxygen species (ROS). Aldehydes physiologically result from numerous processes including the actions of catecholamines and are ubiquitously present in the environment. Normally their potentially noxious effects are kept at bay by the activity of the mitochondrial aldehyde dehydrogenase (ALDH2). Inhibition of ALDH2 by organic nitrates may remove a protective mechanism against oxidative stress. ALDH2 is dysfunctional in up to 30% of Chinese and Japanese; this anomaly is thus estimated to involve at least 0.5 billion persons worldwide
Conversely, nitroglycerin can potently and rapidly inactivate ALDH, including ALDH2,45 an effect that appears to occur prior to onset of nitrate tolerance. Moreover, induction of nitrate tolerance occurs more readily in ALDH2-knockout mice. However, it should also be noted that, apart from wide variability in the interactions between organic nitrates and various ALDH subtypes,48 there are many other nitrate reductases: it therefore seems unlikely that inhibition of ALDH2 is the single key mechanism underlying nitrate tolerance induction. 
  1. Free radical hypothesis: induction of oxidative stress and endothelial dysfunction. A number of studies have linked the development of nitrate tolerance with increases in free radical release, oxidative stress and resultant induction of endothelial dysfunction. Similarly, a number of studies in normal animal models and in normal humans9 have demonstrated that induction of nitrate tolerance may be associated with the induction of vascular endothelial dysfunction. the free radical hypothesis would explain why nitrate tolerance can be lessened acutely in some models by concurrent therapy by vitamin or hydralazine. Other agents that reduce oxidative stress include statins, ACE inhibitors, and ARBs.
27
Q

Concomitant cardiovascular co-therapy (fig. 2-7):
……………. has strong experimental and clinical support. It can attenuate nitrate tolerance induced in rodents by preventing free-radical generation and CYP depletion, and therefore maintaining the activity of the NO–cyclic GMP pathway (see Fig. 2-4).66 Clinically, …………….prevents nitrate tolerance better than a β-blocker.

A

Carvedilol has strong experimental and clinical support. It can attenuate nitrate tolerance induced in rodents by preventing free-radical generation and CYP depletion, and therefore maintaining the activity of the NO–cyclic GMP pathway (see Fig. 2-4).66 Clinically, carvedilol prevents nitrate tolerance better than a β-blocker.

28
Q

Nebivolol is a β-blocker that somewhat paradoxically, is also a β3-adrenoceptor agonist, whereby it activates NOS, thus releasing NO•.67 This unusual property should theoretically help to limit nitrate tolerance.
Hydralazine is logical, especially in CHF because (1) there are strong trial data favoring the nitrate-hydrazine combination, and (2) the hydralazine may overcome the effect of free radical formation.

A

Nebivolol is a β-blocker that somewhat paradoxically, is also a β3-adrenoceptor agonist, whereby it activates NOS, thus releasing NO•.67 This unusual property should theoretically help to limit nitrate tolerance.
Hydralazine is logical, especially in CHF because (1) there are strong trial data favoring the nitrate-hydrazine combination, and (2) the hydralazine may overcome the effect of free radical formation.

29
Q

Nitrate pseudotolerance and rebound

Rebound is the abrupt increase in anginal frequency during accidental nitrate withdrawal (e.g., displacement of an intravenous infusion) or during nitrate-free periods. Nitrate pseudotolerance probably accounts for the “zero-hour phenomenon,” whereby patients receiving long-acting nitrate therapy experience worsening of angina just prior to routine administration of medication. The underlying mechanisms are unopposed vasoconstriction (angiotensin II, catecholamines, and endothelin) during nitrate withdrawal with attenuation of net vasodilator effect of NO•.

A

Rebound is the abrupt increase in anginal frequency during accidental nitrate withdrawal (e.g., displacement of an intravenous infusion) or during nitrate-free periods. Nitrate pseudotolerance probably accounts for the “zero-hour phenomenon,” whereby patients receiving long-acting nitrate therapy experience worsening of angina just prior to routine administration of medication. The underlying mechanisms are unopposed vasoconstriction (angiotensin II, catecholamines, and endothelin) during nitrate withdrawal with attenuation of net vasodilator effect of NO•.

30
Q

Nitric oxide resistance

NO• resistance may be defined as de novo hyporesponsiveness to NO• effects, whether vascular or antiaggregatory. It also occurs with other “direct” donors of NO•, such as sodium nitroprusside. The occurrence of NO• resistance accounts for the finding that some patients with heart failure respond poorly to infused NO• donors, irrespective of prior nitrate exposure. The mechanisms of NO• resistance in platelets relate primarily to incremental redox stress mediated by superoxide anion release. There is a close association between NO• resistance and endothelial dysfunction as in ACS. Platelet resistance to NO• is an adverse prognostic marker.

A

Nitric oxide resistance

NO• resistance may be defined as de novo hyporesponsiveness to NO• effects, whether vascular or antiaggregatory. It also occurs with other “direct” donors of NO•, such as sodium nitroprusside. The occurrence of NO• resistance accounts for the finding that some patients with heart failure respond poorly to infused NO• donors, irrespective of prior nitrate exposure. The mechanisms of NO• resistance in platelets relate primarily to incremental redox stress mediated by superoxide anion release. There is a close association between NO• resistance and endothelial dysfunction as in ACS. Platelet resistance to NO• is an adverse prognostic marker.

31
Q

Other newer antianginal agents
Ivabradine.
Ivabradine (Procoralan) is a blocker of the pacemaker current …. and hence does not act directly on the ………. but indirectly by decreasing the ……… and thus the metabolic demand of the heart.

A

Ivabradine (Procoralan) is a blocker of the pacemaker current If, and hence does not act directly on the metabolism but indirectly by decreasing the heart rate and thus the metabolic demand of the heart.

32
Q

Ivabradine: Its antianginal potency is similar to that of β-blockade and amlodipine. There is no …………. effect nor ……..reduction as with β-blockers, nor any rebound on cessation of therapy.

A

Its antianginal potency is similar to that of β-blockade and amlodipine. There is no negative inotropic effect nor BP reduction as with β-blockers, nor any rebound on cessation of therapy.
Ivabradine is licensed in the United Kingdom and other European countries for use in angina when β-blockers are not tolerated or are contradicted. In practice, it may be combined with β-blockade with clinical benefit, but in this study the β-blocker was not upwardly titrated to achieve maximal heart rate reduction.

33
Q

Ivabradine: Theoretically there is less risk of severe …………… depression than with β-blockade because ………………. is blocked, whereas β-blockade affects all. The downside is that the current If is also found in the retina, so that there may be disturbance of nocturnal vision with flashing lights (phosphenes) that could impair driving at night and is often transient.

A

Theoretically there is less risk of severe sinus node depression than with β-blockade because only one of several pacemaker currents is blocked, whereas β-blockade affects all. The downside is that the current If is also found in the retina, so that there may be disturbance of nocturnal vision with flashing lights (phosphenes) that could impair driving at night and is often transient.

34
Q

Use in heart failure.
The SHIFT study established the clinical benefits of ivabradine in a group of patients with moderate systolic heart failure whose heart rates remained elevated despite β-blockade. Ivabradine reduced cardiovascular mortality and hospital admissions, and also substantially improved quality of life. However, the findings of SHIFT have been challenged. In the Lancet editorial accompanying the SHIFT study, Teerlink questioned whether adequate β-blocker doses had been used. Only 23% of the patients were at trial-established target doses and only half were receiving 50% or more of the targeted β-blocker dose (also see Chapter 6, page 196).

A

The SHIFT study established the clinical benefits of ivabradine in a group of patients with moderate systolic heart failure whose heart rates remained elevated despite β-blockade. Ivabradine reduced cardiovascular mortality and hospital admissions, and also substantially improved quality of life. However, the findings of SHIFT have been challenged. In the Lancet editorial accompanying the SHIFT study, Teerlink questioned whether adequate β-blocker doses had been used. Only 23% of the patients were at trial-established target doses and only half were receiving 50% or more of the targeted β-blocker dose (also see Chapter 6, page 196).

35
Q

In December 2011 The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the approval of the license of ivabradine. The license now includes the treatment of chronic heart failure New York Heart Association level II to IV with systolic dysfunction in patients in sinus rhythm and whose heart rate is 75 bpm or more, in combination with standard therapy including b-blocker therapy or when b-blocker therapy is contraindicated or not tolerated. The CHMP contraindications to use in heart failure are …………. or …………….

A

In December 2011 The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the approval of the license of ivabradine. The license now includes the treatment of chronic heart failure New York Heart Association level II to IV with systolic dysfunction in patients in sinus rhythm and whose heart rate is 75 bpm or more, in combination with standard therapy including b-blocker therapy or when b-blocker therapy is contraindicated or not tolerated. The CHMP contraindications to use in heart failure are unstable or acute heart failure or pacemaker-dependent heart failure (heart rate imposed exclusively by the pacemaker).

36
Q

Allopurinol.
Allopurinol may have a double energy-conserving mechanism. First, it might reduce myocardial oxygen consumption via inhibition of xanthine oxidase. Second, in heart failure allopurinol may act by promoting transfer of high-energy phosphate from creatine phosphate to adenosine triphosphate.106 In keeping with these energy-enhancing concepts, Norman et al.107 performed a double-blind placebo crossover study of high-dose allopurinol (600 mg/day) in patients with stable angina pectoris. They found a moderate increase in time to chest pain and to significant ST depression, thereby establishing an antianginal effect of high-dose allopurinol. Furthermore, this dose of allopurinol reduced vascular oxidative stress and improved endothelial function in patients with CAD.108
Despite the considerable interest arising from these findings, a number of important issues remain unclear. First, the mechanism of action is not clear. Favorable effects on myocardial energetics might underlie the increases in exercise tolerance.106,109 Second, little information is currently available as to the dose-response characteristics of allopurinol in angina, its potency in otherwise refractory cases, or its long-term safety in the high dose used in the study performed by Norman et al.107

A

Allopurinol.
Allopurinol may have a double energy-conserving mechanism. First, it might reduce myocardial oxygen consumption via inhibition of xanthine oxidase. Second, in heart failure allopurinol may act by promoting transfer of high-energy phosphate from creatine phosphate to adenosine triphosphate.106 In keeping with these energy-enhancing concepts, Norman et al.107 performed a double-blind placebo crossover study of high-dose allopurinol (600 mg/day) in patients with stable angina pectoris. They found a moderate increase in time to chest pain and to significant ST depression, thereby establishing an antianginal effect of high-dose allopurinol. Furthermore, this dose of allopurinol reduced vascular oxidative stress and improved endothelial function in patients with CAD.108
Despite the considerable interest arising from these findings, a number of important issues remain unclear. First, the mechanism of action is not clear. Favorable effects on myocardial energetics might underlie the increases in exercise tolerance.106,109 Second, little information is currently available as to the dose-response characteristics of allopurinol in angina, its potency in otherwise refractory cases, or its long-term safety in the high dose used in the study performed by Norman et al.107

37
Q

Are nitrates really safe?
In contrast to the reasonable data for the safety of β-blockers and CCBs in effort angina,110 logic would say that nitrate therapy that leads to excess production of free radicals, endothelial dysfunction, tachycardia, and renin-angiotensin activation may not be safe.111 Analyses of two large databases showed that nitrate use was associated with increased mortality with hazard ratios of 1.6 and 3.8.112 Prolonged nitrate therapy given to Japanese patients for vasospastic angina increased serious cardiac events in a descriptive study.113 At present the best policy may lie in adding short-acting nitrates to β-blockers or CCBs plus the standard cardioprotective drugs such as aspirin, ACE inhibitors, and statins,57 as in the EUROPA study (see Chapter 5).

A

Are nitrates really safe?
In contrast to the reasonable data for the safety of β-blockers and CCBs in effort angina,110 logic would say that nitrate therapy that leads to excess production of free radicals, endothelial dysfunction, tachycardia, and renin-angiotensin activation may not be safe.111 Analyses of two large databases showed that nitrate use was associated with increased mortality with hazard ratios of 1.6 and 3.8.112 Prolonged nitrate therapy given to Japanese patients for vasospastic angina increased serious cardiac events in a descriptive study.113 At present the best policy may lie in adding short-acting nitrates to β-blockers or CCBs plus the standard cardioprotective drugs such as aspirin, ACE inhibitors, and statins,57 as in the EUROPA study (see Chapter 5).

38
Q

Summary
1.
Mechanisms of action. Nitrates act by …………dilation and relief of coronary …………….(including that induced by exercise) to ameliorate anginal attacks. They are also arterial …………., and reduce aortic systolic pressure. Their unloading effects also benefit patients with CHF with high LV filling pressures.

A

Summary
1.
Mechanisms of action. Nitrates act by venodilation and relief of coronary vasoconstriction (including that induced by exercise) to ameliorate anginal attacks. They are also arterial dilators, and reduce aortic systolic pressure. Their unloading effects also benefit patients with CHF with high LV filling pressures.

39
Q

2.
Intermittent nitrates for effort angina. Sublingual nitroglycerin remains the basic therapy, usually combined with a β-blocker, a CCB, or both with careful assessment of lifestyle, BP, and blood lipid profile. As the duration of action lasts for minutes, nitrate tolerance is unusual because of the relatively long …………. intervals between attacks.

Intermittent isosorbide dinitrate has a delayed onset of action because of the need for ……… transformation to active metabolites, yet the duration of action is longer than with nitroglycerin.

A

2.
Intermittent nitrates for effort angina. Sublingual nitroglycerin remains the basic therapy, usually combined with a β-blocker, a CCB, or both with careful assessment of lifestyle, BP, and blood lipid profile. As the duration of action lasts for minutes, nitrate tolerance is unusual because of the relatively long nitrate-free intervals between attacks.

Intermittent isosorbide dinitrate has a delayed onset of action because of the need for hepatic transformation to active metabolites, yet the duration of action is longer than with nitroglycerin.

40
Q

3.
Nitrate tolerance. The longer the duration of nitrate action, the more tolerance is likely to develop. Thus it effectively turns into a balancing act between duration of action and avoidance of tolerance. Down-grading long-acting nitrates to a third-line choice as recommended by NICE, instead of a first-line choice as it is still often used, should lessen the risk of tolerance. Increasing data show that endothelial dysfunction, in which aldehyde formation plays a role, is incriminated in nitrate tolerance. Co-therapy with carvedilol or possibly nebivolol as the β-blockers of choice should help to prevent or delay tolerance, yet prospective clinical trials are lacking.

A

3.
Nitrate tolerance. The longer the duration of nitrate action, the more tolerance is likely to develop. Thus it effectively turns into a balancing act between duration of action and avoidance of tolerance. Down-grading long-acting nitrates to a third-line choice as recommended by NICE, instead of a first-line choice as it is still often used, should lessen the risk of tolerance. Increasing data show that endothelial dysfunction, in which aldehyde formation plays a role, is incriminated in nitrate tolerance. Co-therapy with carvedilol or possibly nebivolol as the β-blockers of choice should help to prevent or delay tolerance, yet prospective clinical trials are lacking.

41
Q

4.
Treatment of CHF. Tolerance also develops during treatment of CHF, so that nitrates are often reserved for specific problems such as acute LV failure, nocturnal dyspnea, or anticipated exercise.

A

4.
Treatment of CHF. Tolerance also develops during treatment of CHF, so that nitrates are often reserved for specific problems such as acute LV failure, nocturnal dyspnea, or anticipated exercise.

42
Q

5.
Acute pulmonary edema. Nitrates are an important part of the overall therapy, acting chiefly by ……………. reduction.

A

Acute pulmonary edema. Nitrates are an important part of the overall therapy, acting chiefly by preload reduction.

43
Q

6.
Nitrate tolerance. The current understanding of the mechanism tolerance focuses on …………………..(superoxide and peroxynitrite) with impaired bioconversion of nitrate to active ………. Besides addition of hydralazine (see previous discussion) other less well-tested measures include administration of antioxidants, statins, ACE inhibitors, and folic acid.

A

Nitrate tolerance. The current understanding of the mechanism tolerance focuses on free radical formation (superoxide and peroxynitrite) with impaired bioconversion of nitrate to active NO•. Besides addition of hydralazine (see previous discussion) other less well-tested measures include administration of antioxidants, statins, ACE inhibitors, and folic acid.

44
Q

7.
Serious interaction with sildenafil-like agents. Nitrates can interact very adversely with such agents, which are now often used to alleviate erectile dysfunction. The latter is common in those with cardiovascular disease, being a manifestation of endothelial dysfunction. The co-administration of these PDE-5 inhibitors with nitrates is therefore contraindicated. If any of these agents has been used, there has to be an interval of 24-48 hours (the longer interval for Cialis) before nitrates can be given therapeutically with reasonable safety but still with great care.

A

Serious interaction with sildenafil-like agents. Nitrates can interact very adversely with such agents, which are now often used to alleviate erectile dysfunction. The latter is common in those with cardiovascular disease, being a manifestation of endothelial dysfunction. The co-administration of these PDE-5 inhibitors with nitrates is therefore contraindicated. If any of these agents has been used, there has to be an interval of 24-48 hours (the longer interval for Cialis) before nitrates can be given therapeutically with reasonable safety but still with great care.

45
Q

8.
Newer antianginal agents. Newer antianginal agents other than nitrates are being increasingly tested and used. These include ivabradine, ranolazine, trimetazidine, perhexiline, and allopurinol. These directly or indirectly help to preserve the myocardial …………… There are relatively few significant side effects.

A

Newer antianginal agents. Newer antianginal agents other than nitrates are being increasingly tested and used. These include ivabradine, ranolazine, trimetazidine, perhexiline, and allopurinol. These directly or indirectly help to preserve the myocardial energy balance. There are relatively few significant side effects.